(Q40047645)

16 September 2017

title

Immunocompetence of cancer patients treated with levamisole (English)

1 reference

10.1002/1097-0142(197702)39:2<487::AID-CNCR2820390217>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C487::AID-CNCR2820390217%3E3.0.CO;2-3

27 December 2022

1 reference

10.1002/1097-0142(197702)39:2<487::AID-CNCR2820390217>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C487::AID-CNCR2820390217%3E3.0.CO;2-3

27 December 2022

author name string

Wilkins SA Jr

1

1 reference

16 September 2017

S. A. Wilkins

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A189894

27 December 2022

Z. L. Olkowski

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A189894

27 December 2022

language of work or name

English

0 references

publication date

1 February 1977

1 reference

full work available at URL

16 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197702)39:2%3C487::AID-CNCR2820390217%3E3.0.CO;2-3

1 reference

10.1002/1097-0142(197702)39:2<487::AID-CNCR2820390217>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C487::AID-CNCR2820390217%3E3.0.CO;2-3

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197702)39:2%3C487::AID-CNCR2820390217%3E3.0.CO;2-3

27 December 2022

1 reference

10.1002/1097-0142(197702)39:2<487::AID-CNCR2820390217>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C487::AID-CNCR2820390217%3E3.0.CO;2-3

27 December 2022

1 reference

16 September 2017

volume

39

1 reference

16 September 2017

issue

2

1 reference

16 September 2017

page(s)

487-493

1 reference

Cyclic Nucleotide-dependent Protein Kinases

16 September 2017

cites work

1 reference

20 October 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/S0021-9258(18)63097-2

Cell-mediated and humoral immune reactions to human tumours

1

1 reference

10.1002/1097-0142(197702)39:2<487::AID-CNCR2820390217>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C487::AID-CNCR2820390217%3E3.0.CO;2-3

Abnormalities of quantitative dinitrochlorobenzene sensitization in cancer patients: correlation with tumor stage and histology

27 December 2022

2

1 reference

10.1002/1097-0142(197702)39:2<487::AID-CNCR2820390217>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C487::AID-CNCR2820390217%3E3.0.CO;2-3

Thymus-dependent lymphocyte levels in bronchogenic carcinoma: Correlations with histology, clinical stage, and clinical course after surgical treatment

27 December 2022

5

1 reference

10.1002/1097-0142(197702)39:2<487::AID-CNCR2820390217>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C487::AID-CNCR2820390217%3E3.0.CO;2-3

Effects of levamisole and imidazole on lymphocyte proliferation and cyclic nucleotide levels

27 December 2022

6

1 reference

10.1002/1097-0142(197702)39:2<487::AID-CNCR2820390217>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C487::AID-CNCR2820390217%3E3.0.CO;2-3

Editorial: Killer T cells

27 December 2022

7

1 reference

10.1002/1097-0142(197702)39:2<487::AID-CNCR2820390217>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C487::AID-CNCR2820390217%3E3.0.CO;2-3

Demonstration of cell-mediated immunity to human neoplasms of various histological types

27 December 2022

8

1 reference

10.1002/1097-0142(197702)39:2<487::AID-CNCR2820390217>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C487::AID-CNCR2820390217%3E3.0.CO;2-3

27 December 2022

9

35

1931

Heppner

1975

1 reference

10.1002/1097-0142(197702)39:2<487::AID-CNCR2820390217>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C487::AID-CNCR2820390217%3E3.0.CO;2-3

A comparative study on in vitro cytotoxic reactions of lymphocytes from normal donors and patients with sarcomas to cultured tumor cells

27 December 2022

11

1 reference

10.1002/1097-0142(197702)39:2<487::AID-CNCR2820390217>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C487::AID-CNCR2820390217%3E3.0.CO;2-3

Protein measurement with the Folin phenol reagent

27 December 2022

14

1 reference

10.1002/1097-0142(197702)39:2<487::AID-CNCR2820390217>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C487::AID-CNCR2820390217%3E3.0.CO;2-3

27 December 2022

15

35

3721

Mukherji

1975

1 reference

10.1002/1097-0142(197702)39:2<487::AID-CNCR2820390217>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C487::AID-CNCR2820390217%3E3.0.CO;2-3

T-lymphocyte levels in the peripheral blood of patients with cancer of the head and neck

27 December 2022

16

1 reference

10.1002/1097-0142(197702)39:2<487::AID-CNCR2820390217>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C487::AID-CNCR2820390217%3E3.0.CO;2-3

Immunocompetence of Patients with Bronchogenic Carcinoma

27 December 2022

20

1 reference

10.1002/1097-0142(197702)39:2<487::AID-CNCR2820390217>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C487::AID-CNCR2820390217%3E3.0.CO;2-3

Immunotherapy of human malignant melanoma with irradiated tumor cells, oral Bacillus Calmette-Guérin, and levamisole

27 December 2022

24

1 reference

10.1002/1097-0142(197702)39:2<487::AID-CNCR2820390217>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C487::AID-CNCR2820390217%3E3.0.CO;2-3

Carrier solutions for low-level intravenous insulin infusion.

27 December 2022

27

1 reference

10.1002/1097-0142(197702)39:2<487::AID-CNCR2820390217>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197702)39:2%3C487::AID-CNCR2820390217%3E3.0.CO;2-3

27 December 2022

Identifiers

10.1002/1097-0142(197702)39:2<487::AID-CNCR2820390217>3.0.CO;2-3

1 reference

16 September 2017

1 reference